跳至主要内容
临床试验/CTRI/2022/04/042162
CTRI/2022/04/042162尚未招募2 期

Efficacy of Bozidan in Hyperuricemia -A Randomized Single Blind Active Controlled Clinical Study.

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients aged between 18-65 years of any gender.
  • 2. Patients with Uric acid >7 mg/dl and < 9.5 mg/dl.
  • 3. Patients having capacity and willingness to give consent and complete trial documentation.

排除标准

  • 1. Patients below 18 years and above 65 years.
  • 2. Patients who are known cases of Renal, Cardiac, Liver and Pulmonary diseases.
  • 3. Pregnant and Lactating females
  • 4. Patient with uncontrolled Hypertension (SBP >140 mmHg, DBP > 90 mmHg, in patients on anti-hypertensive medications).
  • 5. Patients with uncontrolled Diabetes Mellitus (RBS more than the normal range, in patients on hypoglycaemic medications).
  • 6. Use of Uric acid lowering agents prior to 2 weeks of study.
  • 7. Known allergies to test and control drugs.

研究者

发起方
ational Institute of Unani Medicine

相似试验